Integrating Social Determinants of Health in the Management of Cardiovascular-Kidney-Metabolic Syndrome.
作者信息
April-Sanders Ayana K
机构信息
Rutgers School of Public Health Piscataway NJ USA.
出版信息
J Am Heart Assoc. 2024 Aug 20;13(16):e036518. doi: 10.1161/JAHA.124.036518. Epub 2024 Aug 13.
Abstract
摘要
相似文献
1
Integrating Social Determinants of Health in the Management of Cardiovascular-Kidney-Metabolic Syndrome.将健康的社会决定因素纳入心血管-肾脏-代谢综合征的管理中。
J Am Heart Assoc. 2024 Aug 20;13(16):e036518. doi: 10.1161/JAHA.124.036518. Epub 2024 Aug 13.
2
Shaping the Future of "Cardio-Kidney-Metabolic" Health: Insights From The Texas Heart Institute's 2024 Cardiometabolic Syndrome Conference.塑造“心肾代谢”健康的未来：来自德克萨斯心脏研究所2024年心脏代谢综合征会议的见解
Tex Heart Inst J. 2025 Jan 23;52(1):e248536. doi: 10.14503/THIJ-24-8536. eCollection 2025 Jan-Jun.
3
Exploring the High Burden of Cardiovascular Disease Among Patients with End-Stage Renal Disease.探索终末期肾病患者中心血管疾病的高负担情况。
Curr Vasc Pharmacol. 2021;19(1):1-3. doi: 10.2174/157016111901201028093749.
4
Refocusing cardio-renal problems: the cardiovascular-kidney-metabolic syndrome and the chronic cardiovascular-kidney disorder.重新聚焦心肾问题：心血管-肾脏-代谢综合征与慢性心血管-肾脏疾病
Nephrol Dial Transplant. 2024 Aug 30;39(9):1378-1380. doi: 10.1093/ndt/gfae086.
5
Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health.按健康社会决定因素划分的心血管-肾脏-代谢综合征各阶段的流行率。
JAMA Netw Open. 2024 Nov 4;7(11):e2445309. doi: 10.1001/jamanetworkopen.2024.45309.
6
Social Risk Profile and Cardiovascular-Kidney-Metabolic Syndrome in US Adults.美国成年人的社会风险概况与心血管-肾脏-代谢综合征。
J Am Heart Assoc. 2024 Aug 20;13(16):e034996. doi: 10.1161/JAHA.124.034996. Epub 2024 Aug 13.
7
Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology.心血管-肾脏-代谢综合征的定义及其在预防、风险分层和治疗中的作用。肾脏病学面临的一个机遇。
Nefrologia (Engl Ed). 2024 Nov-Dec;44(6):771-783. doi: 10.1016/j.nefroe.2024.11.011. Epub 2024 Dec 6.
8
From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework.从心血管-肾脏-代谢综合征到心血管-肾脏-肝脏-代谢综合征：提出一个扩展框架。
Biomolecules. 2025 Feb 2;15(2):213. doi: 10.3390/biom15020213.
9
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.心血管-肾脏-代谢（CKM）综合征的科学证据和临床管理概要：美国心脏协会的科学声明
Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9.
10
Management of patients with the cardio renal liver metabolic syndrome: The need for a multidisciplinary approach in research, education and practice.心肾肝代谢综合征患者的管理：在研究、教育和实践中采用多学科方法的必要性。
Metabolism. 2024 Oct;159:155997. doi: 10.1016/j.metabol.2024.155997. Epub 2024 Aug 12.
引用本文的文献
1
Associations between Life's Crucial 9 and severity, all-cause mortality, and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: the mediating role of phenotypic age acceleration.心血管-肾脏-代谢综合征患者中生命关键9与疾病严重程度、全因死亡率和心血管死亡率之间的关联：表型年龄加速的中介作用
Front Nutr. 2025 Aug 6;12:1612293. doi: 10.3389/fnut.2025.1612293. eCollection 2025.
2
Cardiovascular-kidney-metabolic syndrome: A new frontier or simple rebranding?心血管-肾脏-代谢综合征：新领域还是简单的重新命名？
PLoS Med. 2025 Aug 21;22(8):e1004723. doi: 10.1371/journal.pmed.1004723. eCollection 2025 Aug.
3
Social determinants of health (SDOH) associated with the risk of all-cause mortality and life expectancy in US adults with cardiovascular-kidney-metabolic syndrome: a NHANES 2001-2018 cohort study.与美国患有心血管-肾脏-代谢综合征的成年人全因死亡率和预期寿命风险相关的健康社会决定因素：一项2001 - 2018年美国国家健康与营养检查调查队列研究
BMC Cardiovasc Disord. 2025 May 15;25(1):369. doi: 10.1186/s12872-025-04812-7.
4
Social Determinants of Health in the Development of Cardiovascular-kidney-metabolic Syndrome.心血管-肾脏-代谢综合征发展过程中的健康社会决定因素
Rev Cardiovasc Med. 2025 Mar 7;26(3):26580. doi: 10.31083/RCM26580. eCollection 2025 Mar.
5
Association between admission serum calcium levels and in‑hospital mortality in acute myocardial infarction patients with cardiovascular-kidney-metabolic syndrome.急性心肌梗死合并心血管-肾脏-代谢综合征患者入院时血清钙水平与院内死亡率的关系
Endocrine. 2025 Mar 29. doi: 10.1007/s12020-025-04217-8.
6
Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study.血浆致动脉粥样硬化指数与心血管-肾脏-代谢综合征1至3期的心血管疾病风险：一项纵向研究。
Front Endocrinol (Lausanne). 2025 Feb 4;16:1517658. doi: 10.3389/fendo.2025.1517658. eCollection 2025.
7
Association of serum Klotho with the severity and mortality among adults with cardiovascular-kidney-metabolic syndrome.血清α-klotho与成人心血管-肾脏-代谢综合征严重程度及死亡率的关联。
Lipids Health Dis. 2024 Dec 18;23(1):408. doi: 10.1186/s12944-024-02400-w.
本文引用的文献
1
Social Risk Profile and Cardiovascular-Kidney-Metabolic Syndrome in US Adults.美国成年人的社会风险概况与心血管-肾脏-代谢综合征。
J Am Heart Assoc. 2024 Aug 20;13(16):e034996. doi: 10.1161/JAHA.124.034996. Epub 2024 Aug 13.
2
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据：美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
3
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.纳入心血管-肾脏-代谢健康因素的全心血管疾病绝对风险评估新预测方程：美国心脏协会科学声明
Circulation. 2023 Dec 12;148(24):1982-2004. doi: 10.1161/CIR.0000000000001191. Epub 2023 Nov 10.
4
Here's What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA.以下是关于美国心脏协会新定义的心血管-肾脏-代谢综合征的相关信息。
JAMA. 2023 Dec 5;330(21):2042-2043. doi: 10.1001/jama.2023.22276.
5
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.心血管-肾脏-代谢健康：美国心脏协会的总统顾问报告
Circulation. 2023 Nov 14;148(20):1606-1635. doi: 10.1161/CIR.0000000000001184. Epub 2023 Oct 9.
6
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.心血管-肾脏-代谢（CKM）综合征的科学证据和临床管理概要：美国心脏协会的科学声明
Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9.
7
Effectiveness of Social Needs Screening and Interventions in Clinical Settings on Utilization, Cost, and Clinical Outcomes: A Systematic Review.临床环境中社会需求筛查与干预对医疗利用、成本及临床结局的有效性：一项系统评价
Health Equity. 2022 Jun 24;6(1):454-475. doi: 10.1089/heq.2022.0010. eCollection 2022.
8
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.国际糖尿病联盟（IDF）糖尿病地图集：2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.
9
Addressing Social Needs in Health Care Settings: Evidence, Challenges, and Opportunities for Public Health.在医疗保健环境中满足社会需求：公共卫生的证据、挑战和机遇。
Annu Rev Public Health. 2021 Apr 1;42:329-344. doi: 10.1146/annurev-publhealth-090419-102204. Epub 2021 Dec 16.
10
Cardiovascular disease in patients with severe mental illness.严重精神疾病患者的心血管疾病。
Nat Rev Cardiol. 2021 Feb;18(2):136-145. doi: 10.1038/s41569-020-00463-7. Epub 2020 Oct 30.
Zotero 插件